Literature DB >> 20400750

Can osteochondral grafting be augmented with microfracture in an extended-size lesion of articular cartilage?

John G Lane1, Robert M Healey, Albert C Chen, Robert L Sah, David Amiel.   

Abstract

BACKGROUND: Both microfracture and osteochondral autografting procedures have been useful in treating osteochondral lesions. HYPOTHESIS: Combining microfracture and osteochondral autografting procedures can extend the size of lesions that can be treated with either technique. STUDY
DESIGN: Descriptive laboratory study.
METHODS: Eight adult goats underwent osteochondral autograft transfer of a 4.5-mm femoral trochlea plug into an 8-mm full-thickness chondral defect. Microfracture was performed in the gap region surrounding the autograft. The animals were allowed normal activity until the end of the experiment at 6 months. At harvest, the knees were assessed grossly, and then evaluation was performed by histology, histomorphometry, biochemistry, and biomechanics.
RESULTS: The osteochondral plugs healed well, with integration of the bone and preservation of the chondral cap. The chondral gap between the host site articular cartilage and the transferred plug had decreased from 3 mm at implant to less than 0.1 mm. Histologic analysis demonstrated regions of variable cartilage repair, with integration of the cartilage layer at some sites but incomplete healing at others. Histomorphometry demonstrated filling of the chondral gap to 75% to 85% of the normal volume. Biochemical analysis revealed greater than 90% type II collagen at most sites, with some areas containing 80% type II collagen. Biomechanical indentation testing indicated that the repaired area had variable thickness and stiffness, with a trend of increased stiffness in the bulk graft and decreased softness at the proximal microfracture interface site.
CONCLUSION: The performance of a combined microfracture and osteochondral autograft transfer procedure to resurface a large chondral defect appears promising. CLINICAL RELEVANCE: This combined technique shows promise for treatment of large chondral defects with a single operative procedure with autogenous tissue that is safe and potentially would have a shorter period of rehabilitation, similar to that of osteochondral transfers and microfracture, in a cost-effective setting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20400750      PMCID: PMC4111625          DOI: 10.1177/0363546510363433

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  36 in total

1.  Update: allograft-associated bacterial infections--United States, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-03-15       Impact factor: 17.586

2.  Microfracture to treat full-thickness chondral defects: surgical technique, rehabilitation, and outcomes.

Authors:  J Richard Steadman; William G Rodkey; Karen K Briggs
Journal:  J Knee Surg       Date:  2002       Impact factor: 2.757

3.  Autologous chondrocyte transplantation. Biomechanics and long-term durability.

Authors:  Lars Peterson; Mats Brittberg; Illka Kiviranta; Evy Lundgren Akerlund; Anders Lindahl
Journal:  Am J Sports Med       Date:  2002 Jan-Feb       Impact factor: 6.202

4.  Two- to 9-year outcome after autologous chondrocyte transplantation of the knee.

Authors:  L Peterson; T Minas; M Brittberg; A Nilsson; E Sjögren-Jansson; A Lindahl
Journal:  Clin Orthop Relat Res       Date:  2000-05       Impact factor: 4.176

5.  Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years.

Authors:  Lars Peterson; Tom Minas; Mats Brittberg; Anders Lindahl
Journal:  J Bone Joint Surg Am       Date:  2003       Impact factor: 5.284

Review 6.  Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up.

Authors:  J Richard Steadman; Karen K Briggs; Juan J Rodrigo; Mininder S Kocher; Thomas J Gill; William G Rodkey
Journal:  Arthroscopy       Date:  2003 May-Jun       Impact factor: 4.772

7.  Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience.

Authors:  László Hangody; Péter Füles
Journal:  J Bone Joint Surg Am       Date:  2003       Impact factor: 5.284

8.  Refrigerated osteoarticular allografts to treat articular cartilage defects of the femoral condyles. A prospective outcomes study.

Authors:  Robert F LaPrade; Jesse Botker; Mary Herzog; Julie Agel
Journal:  J Bone Joint Surg Am       Date:  2009-04       Impact factor: 5.284

9.  Fresh osteochondral allografts.

Authors:  William D Bugbee
Journal:  J Knee Surg       Date:  2002       Impact factor: 2.757

10.  Autologous chondrocyte implantation in the arthritic knee.

Authors:  Tom Minas
Journal:  Orthopedics       Date:  2003-09       Impact factor: 1.390

View more
  12 in total

Review 1.  Biofabrication for osteochondral tissue regeneration: bioink printability requirements.

Authors:  Saba Abdulghani; Pedro G Morouço
Journal:  J Mater Sci Mater Med       Date:  2019-01-28       Impact factor: 3.896

Review 2.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-02-19       Impact factor: 6.389

3.  Cartilage repair and subchondral bone remodeling in response to focal lesions in a mini-pig model: implications for tissue engineering.

Authors:  Matthew B Fisher; Nicole S Belkin; Andrew H Milby; Elizabeth A Henning; Marc Bostrom; Minwook Kim; Christian Pfeifer; Gregory Meloni; George R Dodge; Jason A Burdick; Thomas P Schaer; David R Steinberg; Robert L Mauck
Journal:  Tissue Eng Part A       Date:  2014-12-11       Impact factor: 3.845

4.  Augmenting the articular cartilage-implant interface: Functionalizing with a collagen adhesion protein.

Authors:  Aliza A Allon; Kenneth W Ng; Sommer Hammoud; Brooke H Russell; Casey M Jones; Jose J Rivera; Jeffrey Schwartz; Magnus Hook; Suzzane A Maher
Journal:  J Biomed Mater Res A       Date:  2012-05-21       Impact factor: 4.396

5.  Outcomes of cartilage repair techniques for chondral injury in the hip-a systematic review.

Authors:  Naoki Nakano; Chetan Gohal; Andrew Duong; Olufemi R Ayeni; Vikas Khanduja
Journal:  Int Orthop       Date:  2018-03-13       Impact factor: 3.075

6.  Biofabrication of osteochondral tissue equivalents by printing topologically defined, cell-laden hydrogel scaffolds.

Authors:  Natalja E Fedorovich; Wouter Schuurman; Hans M Wijnberg; Henk-Jan Prins; P René van Weeren; Jos Malda; Jacqueline Alblas; Wouter J A Dhert
Journal:  Tissue Eng Part C Methods       Date:  2011-10-04       Impact factor: 3.056

7.  [Defect models for the regeneration of articular cartilage in large animals].

Authors:  B Schneider-Wald; A K von Thaden; M L R Schwarz
Journal:  Orthopade       Date:  2013-04       Impact factor: 1.087

8.  Treatment of articular cartilage defects in the goat with frozen versus fresh osteochondral allografts: effects on cartilage stiffness, zonal composition, and structure at six months.

Authors:  Andrea L Pallante; Simon Görtz; Albert C Chen; Robert M Healey; Derek C Chase; Scott T Ball; David Amiel; Robert L Sah; William D Bugbee
Journal:  J Bone Joint Surg Am       Date:  2012-11-07       Impact factor: 5.284

9.  Injectable Scaffold for Bone Marrow Stem Cells and Bone Morphogenetic Protein-2 to Repair Cartilage.

Authors:  Raquel Vayas; Ricardo Reyes; María Rosa Arnau; Carmen Évora; Araceli Delgado
Journal:  Cartilage       Date:  2019-04-11       Impact factor: 4.634

10.  Association of 3-Dimensional Cartilage and Bone Structure with Articular Cartilage Properties in and Adjacent to Autologous Osteochondral Grafts after 6 and 12 months in a Goat Model.

Authors:  Elaine F Chan; I-Ling Liu; Eric J Semler; Harold M Aberman; Timothy M Simon; Albert C Chen; Kate G Truncale; Robert L Sah
Journal:  Cartilage       Date:  2012-07-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.